Nagandla H, Thomas C
Receptors (Basel). 2024; 3(2):182-200.
PMID: 39175529
PMC: 11340209.
DOI: 10.3390/receptors3020010.
Saha E, Ben Guebila M, Fanfani V, Fischer J, Shutta K, Mandros P
Biol Sex Differ. 2024; 15(1):62.
PMID: 39107837
PMC: 11302009.
DOI: 10.1186/s13293-024-00634-y.
Saha E, Ben Guebila M, Fanfani V, Fischer J, Shutta K, Mandros P
bioRxiv. 2023; .
PMID: 37790409
PMC: 10543009.
DOI: 10.1101/2023.09.22.559001.
Chen P, Li B, Ou-Yang L
Front Endocrinol (Lausanne). 2022; 13:839005.
PMID: 36060947
PMC: 9433670.
DOI: 10.3389/fendo.2022.839005.
Gangwar S, Kumar A, Yap K, Jose S, Parama D, Sethi G
Pharmaceuticals (Basel). 2022; 15(5).
PMID: 35631448
PMC: 9145966.
DOI: 10.3390/ph15050624.
Expression and clinical implications of estrogen receptors in thoracic malignancies: a narrative review.
Pinton G, Manzotti B, Balzano C, Moro L
J Thorac Dis. 2021; 13(3):1851-1863.
PMID: 33841973
PMC: 8024832.
DOI: 10.21037/jtd-20-2277.
Estrogen Receptor 1 Expression Patterns Have Different Effects on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors' Treatment Response in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma.
Zhang L, Tian M, Lin J, Zhang J, Wang H, Li Z
Front Oncol. 2021; 10:603883.
PMID: 33585221
PMC: 7879979.
DOI: 10.3389/fonc.2020.603883.
Reproductive factors and lung cancer risk: a comprehensive systematic review and meta-analysis.
Yin X, Zhu Z, Hosgood H, Lan Q, Seow W
BMC Public Health. 2020; 20(1):1458.
PMID: 32977782
PMC: 7519481.
DOI: 10.1186/s12889-020-09530-7.
Association between the use of aspirin and risk of lung cancer: results from pooled cohorts and Mendelian randomization analyses.
Jiang Y, Su Z, Li C, Wang R, Wen Y, Liang H
J Cancer Res Clin Oncol. 2020; 147(1):139-151.
PMID: 32965542
DOI: 10.1007/s00432-020-03394-5.
Targeting Toll-like receptor 4 with CLI-095 (TAK-242) enhances the antimetastatic effect of the estrogen receptor antagonist fulvestrant on non-small cell lung cancer.
Fan S, Liao Y, Qiu W, Li L, Li D, Cao X
Clin Transl Oncol. 2020; 22(11):2074-2086.
PMID: 32367494
PMC: 7505887.
DOI: 10.1007/s12094-020-02353-3.
Expression of female sex hormone receptors and its relation to clinicopathological characteristics and prognosis of lung adenocarcinoma.
Lee J, Kim H, Shin B
J Pathol Transl Med. 2019; 54(1):103-111.
PMID: 31718122
PMC: 6986970.
DOI: 10.4132/jptm.2019.10.12.
Expression of estrogen receptor beta and overall survival in non-small cell lung cancer patients: Protocol for a systematic review and meta-analysis of cohort studies.
Chen H, Yan M, Shi W, Shi J, Duan C, Fan Q
Medicine (Baltimore). 2019; 98(43):e17559.
PMID: 31651857
PMC: 6824691.
DOI: 10.1097/MD.0000000000017559.
Reproductive and Hormonal Factors in Relation to Lung Cancer Among Nepali Women.
Vohra S, Sapkota A, Lee M, Pun C, Thakur B, Siwakoti B
Front Oncol. 2019; 9:311.
PMID: 31134144
PMC: 6514227.
DOI: 10.3389/fonc.2019.00311.
Lung Cancer Survival in Lithuania: Changes by Histology, Age, and Sex From 2003-2007 to 2008-2012.
Gedvilaite V, Danila E, Cicenas S, Smailyte G
Cancer Control. 2019; 26(1):1073274819836085.
PMID: 31067990
PMC: 6509983.
DOI: 10.1177/1073274819836085.
17β-estradiol upregulates IL6 expression through the ERβ pathway to promote lung adenocarcinoma progression.
Huang Q, Zhang Z, Liao Y, Liu C, Fan S, Wei X
J Exp Clin Cancer Res. 2018; 37(1):133.
PMID: 29970138
PMC: 6029357.
DOI: 10.1186/s13046-018-0804-5.
Estrogen, Estrogen Receptor and Lung Cancer.
Hsu L, Chu N, Kao S
Int J Mol Sci. 2017; 18(8).
PMID: 28783064
PMC: 5578103.
DOI: 10.3390/ijms18081713.
Exon 7 splicing variant of estrogen receptor α is associated with pathological invasiveness in smoking-independent lung adenocarcinoma.
Suzuki A, Okuda K, Yano M, Oda R, Sakane T, Kawano O
Oncol Lett. 2017; 14(1):891-898.
PMID: 28693248
PMC: 5494717.
DOI: 10.3892/ol.2017.6216.
Cardiac glycosides use and the risk and mortality of cancer; systematic review and meta-analysis of observational studies.
Osman M, Farrag E, Selim M, Osman M, Hasanine A, Selim A
PLoS One. 2017; 12(6):e0178611.
PMID: 28591151
PMC: 5462396.
DOI: 10.1371/journal.pone.0178611.
Clinicopathological significance of oestrogen receptor expression in non-small cell lung cancer.
Chen X, Zheng L, Li Z, Lin T
J Int Med Res. 2016; 45(1):51-58.
PMID: 27913747
PMC: 5536612.
DOI: 10.1177/0300060516666229.
Exploring estrogenic activity in lung cancer.
Slowikowski B, Lianeri M, Jagodzinski P
Mol Biol Rep. 2016; 44(1):35-50.
PMID: 27783191
PMC: 5310573.
DOI: 10.1007/s11033-016-4086-8.